[HTML][HTML] Type II diabetes mellitus: a review on recent drug based therapeutics
S Padhi, AK Nayak, A Behera - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Diabetes mellitus (DM) is a metabolic disorder that occurs in the body because of decreased
insulin activity and/or insulin secretion. Pathological changes such as nephropathy …
insulin activity and/or insulin secretion. Pathological changes such as nephropathy …
The multifunctional role of herbal products in the management of diabetes and obesity: a comprehensive review
Obesity and diabetes are the most demanding health problems today, and their prevalence,
as well as comorbidities, is on the rise all over the world. As time goes on, both are …
as well as comorbidities, is on the rise all over the world. As time goes on, both are …
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review
CY Yang, YR Chen, HT Ou, S Kuo - Cardiovascular Diabetology, 2021 - Springer
Background To conduct a real-word-study-based cost-effectiveness analysis of a GLP-1
receptor agonist (GLP-1RA) versus insulin among type 2 diabetes patients requiring …
receptor agonist (GLP-1RA) versus insulin among type 2 diabetes patients requiring …
[HTML][HTML] Adverse drug events in cost-effectiveness models of pharmacological interventions for diabetes, diabetic retinopathy, and diabetic macular edema: a scoping …
M Pesonen, V Jylhä, E Kankaanpää - JBI Evidence Synthesis, 2024 - journals.lww.com
Objective: The objective of this review was to examine the role of adverse drug events
(ADEs) caused by pharmacological interventions in cost-effectiveness models for diabetes …
(ADEs) caused by pharmacological interventions in cost-effectiveness models for diabetes …
A systematic review on reporting quality of economic evaluations for negotiated glucose-lowering drugs in China national reimbursement drug list
SY Bao, L Liu, FM Li, Y Yang, Y Wei, H Shao… - BMC Health Services …, 2024 - Springer
Background This study aimed to examine the reporting quality of existing economic
evaluations for negotiated glucose-lowering drugs (GLDs) included in China National …
evaluations for negotiated glucose-lowering drugs (GLDs) included in China National …
Pharmacoeconomic Aspects of Diabetes Mellitus: Outcomes and Analysis of Health Benefits Approach
S Baishnab, RS Jaura, S Sharma… - Current Diabetes …, 2024 - benthamdirect.com
Pharmacoeconomics is an important tool for investigating and restructuring healthcare
policies. In India, recent statistical studies have shown that the number of diabetic patients is …
policies. In India, recent statistical studies have shown that the number of diabetic patients is …
Effect of glucagon‐like peptide‐1 receptor agonists in subjects with type 2 diabetes mellitus: A meta‐analysis
W Qian, F Liu, Q Yang - Journal of Clinical Pharmacy and …, 2021 - Wiley Online Library
What is known and objective We performed a meta‐analysis to evaluate the effects of
glucagon‐like peptide‐1 receptor agonists compared to placebo on cardiovascular, kidney …
glucagon‐like peptide‐1 receptor agonists compared to placebo on cardiovascular, kidney …
[PDF][PDF] Awareness survey for antidiabetic drug adverse reaction in community pharmacists (Amravati)
SN Ande, AD Kale, ND Deshmukh, RL Bakal - 2022 - innpharmacotherapy.com
Introduction: Adverse drug reaction (ADR) data from other countries may neglect care trends
in local populations; hence, active national pharmacovigilance initiatives are required. Any …
in local populations; hence, active national pharmacovigilance initiatives are required. Any …